Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes

M Arabpour, A Saghazadeh, N Rezaei - International …, 2021 - Elsevier
Mesenchymal stem cells (MSCs) are multipotent cells beneficial in regenerative medicine
and tissue repair. The therapeutic potential of MSCs for inflammatory diseases and …

[HTML][HTML] Exosome nanovesicles: a potential carrier for therapeutic delivery

VP Chavda, A Pandya, L Kumar, N Raval, LK Vora… - Nano Today, 2023 - Elsevier
Exosomes are small nanosized biovesicles that form when multivesicular bodies and the
plasma membrane fuse and are released into the surrounding body fluids. They are best …

Recent advances in regenerative biomaterials

D Cao, J Ding - Regenerative Biomaterials, 2022 - academic.oup.com
Nowadays, biomaterials have evolved from the inert supports or functional substitutes to the
bioactive materials able to trigger or promote the regenerative potential of tissues. The …

Exosome-based vaccines: history, current state, and clinical trials

P Santos, F Almeida - Frontiers in immunology, 2021 - frontiersin.org
Extracellular vesicles (EVs) are released by most cell types as part of an intracellular
communication system in crucial processes such as inflammation, cell proliferation, and …

Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: an …

X Xu, W Jiang, L Chen, Z Xu, Q Zhang… - Clinical and …, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …

Immune mechanisms of pulmonary fibrosis with bleomycin

Y Ishida, Y Kuninaka, N Mukaida, T Kondo - International journal of …, 2023 - mdpi.com
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function,
often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and …

A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021

D Ma, B Guan, L Song, Q Liu, Y Fan, L Zhao… - Frontiers in …, 2021 - frontiersin.org
Background: Exosomes in cardiovascular diseases (CVDs) have become an active research
field with substantial value and potential. Nevertheless, there are few bibliometric studies in …

MSCs vs. iPSCs: Potential in therapeutic applications

K Thanaskody, AS Jusop, GJ Tye… - Frontiers in Cell and …, 2022 - frontiersin.org
Over the past 2 decades, mesenchymal stem cells (MSCs) have attracted a lot of interest as
a unique therapeutic approach for a variety of diseases. MSCs are capable of self-renewal …

Nanomedicine for the SARS-CoV-2: state-of-the-art and future prospects

SP Varahachalam, B Lahooti… - International journal …, 2021 - Taylor & Francis
The newly emerged ribonucleic acid (RNA) enveloped human beta-coronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused the COVID-19 …

Effect of SARS-CoV-2 proteins on vascular permeability

R Rauti, M Shahoha, Y Leichtmann-Bardoogo… - Elife, 2021 - elifesciences.org
Severe acute respiratory syndrome (SARS)-CoV-2 infection leads to severe disease
associated with cytokine storm, vascular dysfunction, coagulation, and progressive lung …